Jennifer Doudna Net Worth

Jennifer Doudna biography

Dr. Jennifer A. Doudna Ph.D. serves as Independent Director of the Company. She joined the faculty at University of California, Berkeley, as a Professor of Biochemistry & Molecular Biology in 2002. She directs the Innovative Genomics Institute, a joint UC Berkeley-UC San Francisco center, holds the Li Ka Shing Chancellor's Professorship in Biomedical and Health, and is the Chair of the Chancellor's Advisory Committee on Biology at UC Berkeley. Dr. Doudna is Principal Investigator at the Doudna Lab at UC Berkeley and has founded and serves on the Scientific Advisory Boards of Caribou Biosciences, Inc. and Intellia Therapeutics, Inc., both leading CRISPR genome engineering companies. She has been an Investigator with the Howard Hughes Medical Institute since 1997. Dr. Doudna is the recipient of numerous scientific awards in biochemistry and genetics. Dr. Doudna is a Director of Driver Inc. and a Trustee for Pomona College.

What is the salary of Jennifer Doudna?

As the Independent Director of Johnson & Johnson, the total compensation of Jennifer Doudna at Johnson & Johnson is $324,979. There are 18 executives at Johnson & Johnson getting paid more, with Alex Gorsky having the highest compensation of $25,365,800.

How old is Jennifer Doudna?

Jennifer Doudna is 56, he's been the Independent Director of Johnson & Johnson since 2018. There are 22 older and 8 younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Ronald Williams, 70, who is the Independent Director.

What's Jennifer Doudna's mailing address?

Jennifer's mailing address filed with the SEC is ONE JOHNSON & JOHNSON PLAZA, , NEW BRUNSWICK, NJ, 08933.

Insiders trading at Johnson & Johnson

Over the last 22 years, insiders at Johnson & Johnson have traded over $59,929,946 worth of Johnson & Johnson stock and bought 21,998 units worth $2,578,685 . The most active insiders traders include Hubert Joly, Anne M Mulcahy a Alex Gorsky. On average, Johnson & Johnson executives and independent directors trade stock every 21 days with the average trade being worth of $4,572,436. The most recent stock trade was executed by Robert J Decker on 30 August 2024, trading 5,635 units of JNJ stock currently worth $563,838.

What does Johnson & Johnson do?

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.

Johnson & Johnson executives and stock owners

Johnson & Johnson executives and other stock owners filed with the SEC include:

• Alex Gorsky,
  Chairman of the Board, Chief Executive Officer
• Paulus Stoffels,
  Vice Chairman- Executive Committee, Chief Scientific Officer
• Joaquin Duato,
  Vice Chairman - Executive Committee
• Joseph Wolk,
  Chief Financial Officer, Executive Vice President
• Jennifer Taubert,
  Executive Vice President - Worldwide Chairman, Pharmaceuticals
• Michael Ullmann,
  Executive Vice President, General Counsel
• Alex Gorsky,
  Exec. Chairman
• Peter Fasolo,
  Chief Human Resource Officer, Executive Vice President
• Dr. Paulus A. Stoffels M.D., Ph.D.,
  Chief Scientific Officer
• Joaquin Duato,
  CEO & Director
• Joseph J. Wolk CPA,
  Exec. VP & CFO
• Joseph J. Wolk C.P.A.,
  Exec. VP & CFO
• Jennifer L. Taubert,
  Exec. VP & Worldwide Chairman of Pharmaceuticals
• Anne Mulcahy,
  Lead Independent Director
• Charles Prince,
  Independent Director
• Mary Beckerle,
  Independent Director
• Ronald Williams,
  Independent Director
• D. Scott Davis,
  Independent Director
• A. Eugene Washington,
  Independent Director
• Jennifer Doudna,
  Independent Director
• Mark McClellan,
  Independent Director
• Ian Davis,
  Independent Director
• Marillyn Hewson,
  Independent Director
• Mark Weinberger,
  Independent Director
• Hubert Joly,
  Independent Director
• Christopher DelOrefice,
  Vice President, Investor Relations
• Kathryn Wengel,
  Executive Vice President, Chief Global Supply Chain Officer
• Michael Sneed,
  Executive Vice President - Global Corporate Affairs and Chief Communication Officer
• Thibaut Mongon,
  Executive Vice President, Worldwide Chairman, Consumer
• Ashley McEvoy,
  Executive Vice President - Worldwide Chairman, Medical Devices
• Dr. Guy J. Lebeau M.D.,
  Group Chairman of MD&D Bus. - EMEA
• Dr. Peter M. Fasolo Ph.D.,
  Exec. VP & Chief HR Officer
• Michael H. Ullmann,
  Exec. VP & Gen. Counsel
• Jessica Moore,
  VP of Investor Relations
• Ashley Watson,
  Chief Compliance Officer
• James Swanson,
  Exec. VP & Global CIO
• Robert J. Decker Jr.,
  Controller & Chief Accounting Officer
• James Cullen,
  Director
• Stephen J Cosgrove,
  
• Leo F Mullin,
  Director
• Michael M E Johns,
  Director
• Robert J Decker,
  VP Corporate Controller
• Elizabeth Forminard,
  Executive VP, General Counsel
• Ronald A Kapusta,
  Controller, CAO
• Susan L Lindquist,
  Director
• Gary J Pruden,
  Exec VP, WW Chair, Med Devices
• William D Perez,
  Director
• Jorge S. Mesquita,
  Exec VP, WW Chair, Consumer
• Dominic J Caruso,
  Chief Financial Officer
• Timothy Schmid,
  EVP, WW Chair, MedTech
• Mary Sue Coleman,
  Director
• David Satcher,
  Director
• William C Weldon,
  Chairman/CEO
• Arnold G Langbo,
  Director
• Russell C Deyo,
  Vice President, Administration
• Kaye I Foster Cheek,
  VP, Human Resources
• Colleen A Goggins,
  Member, Executive Committee
• Sherilyn S Mc Coy,
  Member, Executive Committee
• Donald M Jr. Casey,
  Member, Executive Committee
• Nicholas J Valeriani,
  Vice President,Human Resources
• Christine A Poon,
  Executive Committee Member
• Joseph C Scodari,
  Executive Committee Member
• Steven Reinemund,
  Director
• Ann Dibble Jordan,
  Director
• Robert J Darretta,
  Member, Executive Committee
• Per A Peterson,
  Executive Committee Member
• Michael J Dormer,
  Member, Executive Committee
• Joann Heffernan Heisen,
  Member, Executive Committee
• Gerard N Burrow,
  Director
• Henry B Schacht,
  Director
• M Judah Folkman,
  Director
• Roger S Fine,
  Vice President General Counsel
• James T Lenehan,
  Vice Chairman
• Brian D Perkins,
  Executive Committee Member
• Robert N Wilson,
  
• Nadja West,
  Director
• Vanessa Broadhurst,
  EVP, Global Corp Affairs
• Mathai Mammen,
  EVP, Pharm, R&D
• William Hait,
  EVP, Chief EI and Med Officer
• Darius Adamczyk,
  Director
• James D. Swanson,
  EVP, CIO
• John C Reed,
  EVP, Innovative Medicine, R&D
• Paula A Johnson,
  Director
• Eugene A. Woods,
  Director